Second Amendment to Employment Agreement between Aspira Women’s Health Inc. and Dr. Torsten Hombeck
This amendment updates the employment agreement between Aspira Women’s Health Inc. and Dr. Torsten Hombeck, effective June 1, 2024. It changes Dr. Hombeck’s position to Chief Financial Officer and Corporate Secretary and sets his annual base salary at $375,000, paid according to company payroll policies. All other terms of the original agreement remain unchanged. The amendment is effective upon signature by both parties.
EX.10.1
SECOND AMENDMENT
TO
Employment Agreement
This SECOND AMENDMENT (the “Second Amendment”), dated as of June 5, 2024, (the “Second Amendment Date”) to the Employment Agreement (the “Employment Agreement”), dated May 16, 2023 (“Effective Date”), is made by and among Dr. Torsten Hombeck (“Executive”) and Aspira Women’s Health Inc. and is effective as of June 1, 2024, for itself and on behalf of its wholly owned affiliates (collectively “Aspira” or “Company”).
RECITALS
NOW, THEREFORE, in consideration of these premises and the covenants set forth below, and for good and valuable consideration, Executive and Company hereby amend the Agreements as follows:
AGREEMENT
“The Company will employ Executive as its Chief Financial Officer and Corporate Secretary.”
2. Base and Bonus:as follows:
The Company will pay Executive a base salary of $375,000.00 on an annualized basis, payable in accordance with the Company’s standard payroll policies, including compliance with applicable tax withholding requirements based on Executive’s state of residence.
[Signature page to follow]
IN WITNESS WHEREOF, the Parties have executed this Amendment on the date first written above.
Dr. Torsten Hombeck
| ASPIRA WOMEN’S HEALTH INC.
|
By: _/s/ Torsten Hombeck Name: Dr. Torsten Hombeck_ Title: _CFO___________ | By: _/s/ Nicole Sandford Name: Nicole Sandford_ Title: _CEO___________ |